Breakthrough Cooperation of Legend Capital’s Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM
Breakthrough Cooperation of Legend Capital’s Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM

HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – On June 14, two of Legend Capital’s portfolio companies, Innovent Biologics, Inc. (“Innovent”) and PT Etana Biotechnologies Indonesia (“Etana”), jointly announced that the Indonesian Food and Drugs Authority (BPOM) had approved Bevagen (bevacizumab biosimilar), a recombinant humanized anti-VEGF monoclonal antibody drug for five indications... » read more

Legend Capital’s Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China
Legend Capital’s Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China

HONG KONG, Apr 24, 2022 – (ACN Newswire via SEAPRWire.com) – Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital’s co-founded company Innostellar Biotherapeutics, announced that the clinical trial application of its product LX101 injection for the treatment of patients with Rpe65 biallelic mutation-associated inherited retinal degenerations (IRD) was approved by the Center for... » read more

Legend Capital’s Portfolio Company Recbio Lists on HKEX Successfully
Legend Capital’s Portfolio Company Recbio Lists on HKEX Successfully

HONG KONG, Apr 7, 2022 – (ACN Newswire via SEAPRWire.com) – On 31 March 2022, Legend Capital’s portfolio company Jiangsu Recbio Technology Co., Ltd. (“Recbio”, stock code: 2179.HK), a leading novel vaccines company, went public on the Hong Kong Stock Exchange. The listing makes Recbio “the first HPV vaccine stock in Hong Kong” and “the... » read more

Legend Holdings (3396.HK) Announced 2021 Annual Results

HONG KONG, Apr 1, 2022 – (ACN Newswire via SEAPRWire.com) – According to South China Morning Post, Global market experienced another rock year. The impact of COVID-19 still not got away, the chaos of global supply chain showed that the world still need time to recover; the aftermath of geopolitical factors heavily disturbed the global... » read more

Legend Holdings: Remaining True to the Original Aspiration, Leading by Technology, and Serving the Country through Industry

HONG KONG, Mar 31, 2022 – (ACN Newswire via SEAPRWire.com) – Legend Holdings Corporation (3396.HK) announced today the audited annual results of the 12 months ended December 31, 2021(“Reporting Period”). In 2021, the Company’s revenue was RMB489.872 billion, representing a year-on-year increase of 17%; net profit attributable to equity holders of the Company amounted to... » read more

Legend Capital leads ForQaly Medical’s Series B financing
Legend Capital leads ForQaly Medical’s Series B financing

HONG KONG, Oct 8, 2021 – (ACN Newswire via SEAPRWire.com) – ForQaly Medical (hereinafter referred to as “ForQaly”), located in Shanghai Zhangjiang International Medical Zone, is a leading high-tech company focused on developing micro-traumatic circulatory assistant devices. Recently, it completed its Series B fundraising led by Legend Capital, followed by CD Capital, SAIF Partners, Chengwei... » read more

Football: Pele recovering well in Brazil hospital, says daughter

SAO PAULO (REUTERS) – Brazil soccer legend Pele is “recovering well” after colon surgery, his daughter said on Friday (Sept 17), addressing concerns about his health following newspaper reports he had been readmitted to an intensive care unit. “He is recovering well and within normal range. I promise!” Pele’s daughter Kely Nascimento said on Instagram.... » read more

Legend Capital Led a New Round of Investment of Etana
Legend Capital Led a New Round of Investment of Etana

HONG KONG, Sep 14, 2021 – (ACN Newswire via SEAPRWire.com) – Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent) (HKEX: 01801), and a consortium led by UOB Venture Management (UOBVM). This round of funds will be used to further strengthen the company’s production,... » read more

Legend Holdings Announces 2021 Interim Results, Revenue and Net Profit Attributable to Equity Holders Recorded a Historical High

HONG KONG, Sep 2, 2021 – (ACN Newswire via SEAPRWire.com) – According to South China Morning Post, in the first half of 2021, the uncertainty of the COVID-19 threatened the global economic recovery, while China benefited from the good control of the epidemic situation, the economy continued to recover steadily, production and market demand continued... » read more

Legend Holdings Revenue and Net Profit Attributable to Equity Holders of the Company Stood at RMB 228.57 Billion and RMB 4.69 Billion in 1H2021

HONG KONG, Sep 1, 2021 – (ACN Newswire via SEAPRWire.com) – Legend Holdings Corporation (“Legend Holdings” or the “Company”; stock code: 3396.HK) announced the unaudited interim results of the six months ended June 30, 2021 (the “Reporting Period”) on August 31, 2021. During the Reporting Period, the Company’s revenue was RMB 228.57 billion, representing a... » read more